rs775224457
Variant summary
Our verdict is Pathogenic. The variant received 14 ACMG points: 14P and 0B. PM5PP3_StrongPP5_Very_Strong
The NM_138387.4(G6PC3):c.130C>T(p.Pro44Ser) variant causes a missense change. The variant allele was found at a frequency of 0.0000192 in 1,461,514 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P44L) has been classified as Pathogenic.
Frequency
Consequence
NM_138387.4 missense
Scores
Clinical Significance
Conservation
Publications
- autosomal recessive severe congenital neutropenia due to G6PC3 deficiencyInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 14 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| G6PC3 | NM_138387.4 | c.130C>T | p.Pro44Ser | missense_variant | Exon 1 of 6 | ENST00000269097.9 | NP_612396.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| G6PC3 | ENST00000269097.9 | c.130C>T | p.Pro44Ser | missense_variant | Exon 1 of 6 | 1 | NM_138387.4 | ENSP00000269097.3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.0000359 AC: 9AN: 250348 AF XY: 0.0000665 show subpopulations
GnomAD4 exome AF: 0.0000192 AC: 28AN: 1461514Hom.: 0 Cov.: 31 AF XY: 0.0000261 AC XY: 19AN XY: 727000 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency Pathogenic:3Other:1
- -
Variant summary: G6PC3 c.130C>T (p.Pro44Ser) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 3.6e-05 in 250348 control chromosomes. c.130C>T has been observed in multiple individuals affected with Autosomal Recessive Severe Congenital Neutropenia Due To G6PC3 Deficiency (e.g. Banka_2011, Hayee_2011, Stary-Pedersen_2017). These data indicate that the variant is very likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function. The most pronounced variant effect results in <10% of normal activity (Lin_2015). The following publications have been ascertained in the context of this evaluation (PMID: 21264919, 21385794, 25492228, 27577878).ClinVar contains an entry for this variant (Variation ID: 189781). Based on the evidence outlined above, the variant was classified as pathogenic. -
This sequence change replaces proline, which is neutral and non-polar, with serine, which is neutral and polar, at codon 44 of the G6PC3 protein (p.Pro44Ser). This variant is present in population databases (rs775224457, gnomAD 0.03%). This missense change has been observed in individual(s) with G6PC3-related conditions (PMID: 21385794, 22469094, 27577878, 29163546). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 189781). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt G6PC3 protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects G6PC3 function (PMID: 25492228). This variant disrupts the p.Pro44 amino acid residue in G6PC3. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 22050868, 25492228, 31321910, 32623377). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
- -
not provided Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at